Literature DB >> 29371297

Personalised medicine in general practice: the example of raised cholesterol.

Nadeem Qureshi1, Steve E Humphries2, Huon Gray3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29371297      PMCID： PMC5774941          DOI： 10.3399/bjgp18X694481

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  6 in total

1.  Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.

Authors:  Philippa J Talmud; Sonia Shah; Ros Whittall; Marta Futema; Philip Howard; Jackie A Cooper; Seamus C Harrison; Kawah Li; Fotios Drenos; Frederik Karpe; H Andrew W Neil; Olivier S Descamps; Claudia Langenberg; Nicholas Lench; Mika Kivimaki; John Whittaker; Aroon D Hingorani; Meena Kumari; Steve E Humphries
Journal:  Lancet       Date:  2013-02-22       Impact factor: 79.321

2.  The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.

Authors:  R A Wilke; L B Ramsey; S G Johnson; W D Maxwell; H L McLeod; D Voora; R M Krauss; D M Roden; Q Feng; R M Cooper-Dehoff; L Gong; T E Klein; M Wadelius; M Niemi
Journal:  Clin Pharmacol Ther       Date:  2012-05-23       Impact factor: 6.875

Review 3.  Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

Authors:  Nadeem Qureshi; Steve E Humphries; Mary Seed; Philip Rowlands; Rubin Minhas
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

4.  Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).

Authors:  Stephen F Weng; Joe Kai; H Andrew Neil; Steve E Humphries; Nadeem Qureshi
Journal:  Atherosclerosis       Date:  2014-12-20       Impact factor: 5.162

5.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Authors:  Andrew Neil; Jackie Cooper; John Betteridge; Nigel Capps; Ian McDowell; Paul Durrington; Mary Seed; Steve E Humphries
Journal:  Eur Heart J       Date:  2008-10-07       Impact factor: 29.983

6.  Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK.

Authors:  Marion Kerr; Robert Pears; Zofia Miedzybrodzka; Kate Haralambos; Moyra Cather; Melanie Watson; Steve E Humphries
Journal:  Eur Heart J       Date:  2017-06-14       Impact factor: 29.983
  6 in total
  2 in total

1.  Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.

Authors:  Luisa Silva; Laura Condon; Nadeem Qureshi; Brittany Dutton; Stephen Weng; Joe Kai
Journal:  Br J Gen Pract       Date:  2022-06-30       Impact factor: 6.302

2.  Representations of personalised medicine in family medicine: a qualitative analysis.

Authors:  Marie S Boyer; Daniel Widmer; Christine Cohidon; Béatrice Desvergne; Jacques Cornuz; Idris Guessous; Daniela Cerqui
Journal:  BMC Prim Care       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.